Literature DB >> 18670429

Trends in disease focus of drug development.

Johan P E Karlberg.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18670429     DOI： 10.1038/nrd2618

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  The role of funding and policies on innovation in cancer drug development.

Authors:  P Kanavos; R Sullivan; G Lewison; W Schurer; S Eckhouse; Z Vlachopioti
Journal:  Ecancermedicalscience       Date:  2010-02-03

2.  Advances in Nuclear Magnetic Resonance for Drug Discovery.

Authors:  Robert Powers
Journal:  Expert Opin Drug Discov       Date:  2009-10-01       Impact factor: 6.098

3.  The ideological divide in confidence in science and participation in medical research.

Authors:  Matthew Gabel; Jonathan Gooblar; Catherine M Roe; John C Morris
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

4.  First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting.

Authors:  Andrea Molckovsky; Lillian L Siu
Journal:  J Hematol Oncol       Date:  2008-10-29       Impact factor: 17.388

Review 5.  New Zealand's drug development industry.

Authors:  Michelle Marie Lockhart; Zaheer-Ud-Din Babar; Christopher Carswell; Sanjay Garg
Journal:  Int J Environ Res Public Health       Date:  2013-09-13       Impact factor: 3.390
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.